SLC12A2
Basic information
Region (hg38): 5:128083766-128189677
Links
Phenotypes
GenCC
Source:
- schizophrenia (No Known Disease Relationship), mode of inheritance: Unknown
- autosomal recessive non-syndromic intellectual disability (Supportive), mode of inheritance: AR
- syndromic intellectual disability (Supportive), mode of inheritance: AD
- hearing loss, autosomal dominant 78 (Strong), mode of inheritance: AD
- Delpire-McNeill syndrome (Strong), mode of inheritance: AD
- Kilquist syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Deafness, autosomal dominant 78; Delpire-McNeill syndrome; Kilquist syndrome | AD/AR | Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Pulmonary | The conditions can include early-onset hearing loss, and early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; In Kilquist syndrome, antiinfectious prophylaxis and early and aggressive treatment of infections, as well as aggressive pulmonary care, may be beneficial | Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Gastrointestinal; Musculoskeletal; Neurologic; Pulmonary | 30740830; 32658972; 32754646 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (4 variants)
- SLC12A2-related disorder (1 variants)
- Sensorineural hearing loss disorder (1 variants)
- Inborn genetic diseases (1 variants)
- Kilquist syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC12A2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 61 | 68 | ||||
missense | 191 | 12 | 207 | |||
nonsense | 8 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 21 | 27 | ||||
splice donor/acceptor (+/-2bp) | 5 | |||||
splice region | 5 | 5 | 1 | 11 | ||
non coding | 42 | 25 | 70 | |||
Total | 6 | 5 | 222 | 119 | 37 |
Highest pathogenic variant AF is 0.00000659
Variants in SLC12A2
This is a list of pathogenic ClinVar variants found in the SLC12A2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-128083958-G-C | Uncertain significance (Aug 30, 2023) | |||
5-128083972-G-C | SLC12A2-related disorder | Likely benign (Dec 26, 2023) | ||
5-128083995-G-T | Kilquist syndrome;Hearing loss, autosomal dominant 78;Delpire-McNeill syndrome • Inborn genetic diseases | Uncertain significance (Dec 11, 2023) | ||
5-128083999-G-C | Likely benign (Aug 01, 2024) | |||
5-128084006-G-T | Inborn genetic diseases | Uncertain significance (Jun 12, 2023) | ||
5-128084018-C-T | Inborn genetic diseases | Uncertain significance (Nov 09, 2023) | ||
5-128084031-CGCTGGCCGCAGCCAGGGTGGAACT-C | Uncertain significance (Dec 17, 2022) | |||
5-128084053-A-G | Benign (Jul 16, 2022) | |||
5-128084056-G-A | Delpire-McNeill syndrome;Kilquist syndrome;Hearing loss, autosomal dominant 78 | Benign/Likely benign (Mar 01, 2024) | ||
5-128084067-C-G | Uncertain significance (Jun 01, 2024) | |||
5-128084073-C-T | Delpire-McNeill syndrome | Uncertain significance (May 20, 2023) | ||
5-128084074-C-T | Likely benign (Aug 18, 2023) | |||
5-128084081-C-G | Uncertain significance (Jul 01, 2022) | |||
5-128084091-C-T | Uncertain significance (Nov 06, 2023) | |||
5-128084099-G-C | Uncertain significance (Aug 23, 2022) | |||
5-128084101-G-C | Likely benign (Sep 18, 2023) | |||
5-128084101-G-T | Benign (Jun 01, 2024) | |||
5-128084108-G-A | Delpire-McNeill syndrome | Uncertain significance (-) | ||
5-128084110-C-G | Benign (Aug 01, 2024) | |||
5-128084113-C-T | Likely benign (Mar 10, 2022) | |||
5-128084131-G-T | Uncertain significance (Jun 10, 2023) | |||
5-128084133-G-T | Inborn genetic diseases | Uncertain significance (May 25, 2022) | ||
5-128084138-G-A | Uncertain significance (May 15, 2023) | |||
5-128084144-G-A | Uncertain significance (Sep 01, 2022) | |||
5-128084150-G-A | Inborn genetic diseases | Uncertain significance (Jun 21, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC12A2 | protein_coding | protein_coding | ENST00000262461 | 27 | 105923 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.962 | 0.0385 | 125714 | 0 | 20 | 125734 | 0.0000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.40 | 430 | 594 | 0.723 | 0.0000293 | 7818 |
Missense in Polyphen | 135 | 259.89 | 0.51945 | 3207 | ||
Synonymous | -0.473 | 222 | 213 | 1.04 | 0.0000107 | 2407 |
Loss of Function | 5.77 | 11 | 58.7 | 0.188 | 0.00000309 | 736 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000127 | 0.000126 |
Ashkenazi Jewish | 0.0000998 | 0.0000992 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000115 | 0.000114 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.0000350 | 0.0000327 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Electrically silent transporter system. Mediates sodium and chloride reabsorption. Plays a vital role in the regulation of ionic balance and cell volume.;
- Pathway
- Vibrio cholerae infection - Homo sapiens (human);Salivary secretion - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;miR-targeted genes in squamous cell - TarBase;Cation-coupled Chloride cotransporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules
(Consensus)
Recessive Scores
- pRec
- 0.315
Intolerance Scores
- loftool
- 0.0758
- rvis_EVS
- -1.31
- rvis_percentile_EVS
- 4.88
Haploinsufficiency Scores
- pHI
- 0.229
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.559
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.757
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc12a2
- Phenotype
- homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; digestive/alimentary phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- slc12a2
- Affected structure
- melanocyte
- Phenotype tag
- abnormal
- Phenotype quality
- area
Gene ontology
- Biological process
- ion transport;cell volume homeostasis;hyperosmotic response;gamma-aminobutyric acid signaling pathway;aging;T cell chemotaxis;ammonium transport;transepithelial chloride transport;sodium ion transmembrane transport;positive regulation of cell volume;chloride ion homeostasis;potassium ion homeostasis;sodium ion homeostasis;transepithelial ammonium transport;ammonium transmembrane transport;chloride transmembrane transport;potassium ion import across plasma membrane;cellular response to chemokine
- Cellular component
- plasma membrane;integral component of plasma membrane;membrane;apical plasma membrane;extracellular exosome;extracellular vesicle
- Molecular function
- protein binding;sodium:potassium:chloride symporter activity;ammonium transmembrane transporter activity;sodium ion transmembrane transporter activity;sodium:chloride symporter activity;potassium:chloride symporter activity;protein kinase binding